Patents by Inventor S.J.L Bakker

S.J.L Bakker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Procalcitonin for the prognosis of adverse events
    Patent number: 11835531
    Abstract: An in vitro method for the prognosis of an adverse event in asymptomatic subjects comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from the subject and the correlation of the determined level to a potential risk of sustaining an adverse event.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: December 5, 2023
    Assignee: B.R.A.H.M.S GmbH
    Inventors: Joachim Struck, S. J. L. Bakker
  • PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS
    Publication number: 20190227081
    Abstract: The present invention relates to an in vitro method for the prognosis of an adverse event in asymptomatic subjects comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said subject and the correlation of the determined level to a potential risk of sustaining an adverse event.
    Type: Application
    Filed: April 8, 2019
    Publication date: July 25, 2019
    Applicant: B.R.A.H.M.S GmbH
    Inventors: Joachim STRUCK, S.J.L. BAKKER
  • PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS
    Publication number: 20120149131
    Abstract: The present invention relates to an in vitro method for the prognosis of an adverse event in asymptomatic subjects comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said subject and the correlation of the determined level to a potential risk of sustaining an adverse event.
    Type: Application
    Filed: August 27, 2010
    Publication date: June 14, 2012
    Applicant: B.R.A.H.M.S GmbH
    Inventors: Joachim Struck, S.J.L. Bakker
  • MARKER FOR GRAFT FAILURE AND MORTALITY
    Publication number: 20110171750
    Abstract: Subject of the present invention is a biomarker for graft failure and/or mortality after organ transplantation. Procalcitonin was found to be a useful marker for the prediction or risk stratification for graft failure and/or mortality of a subject who has received an organ transplant and monitoring and therapy guidance of such subject.
    Type: Application
    Filed: May 29, 2009
    Publication date: July 14, 2011
    Inventors: Joachim Struck, S.J.L Bakker